The FDA is now looking to weave our patient voices into the regulatory process even more, and they need to hear from us in the next three days on how best to do that.
o many posts from the diabetes blogging community, so many advocacy efforts — it’s tough to select just a handful to highlight here. But in keeping with the spirit of our monthly DOC Blog Roundup, here’s a rundown of some of the great stuff that caught our eye in November, in no particular order.
New research on diabetes suggests that nearly 30% of adults with diabetes remain undiagnosed—the same rate as people with HIV. And just like many HIV patients, only about 20% of diabetes patients are treated satisfactorily, finds the new study published in the Annals of Internal Medicine.
The evidence has been piling up that properly done CT scans can help doctors find tiny lung tumors in longtime smokers while the cancer can still be treated effectively. Now Medicare is proposing to pay for annual scans for beneficiaries at a high risk for lung cancer. To qualify, patients would have to first meet […]
After hours of planning and anticipation, we were thrilled to see all of the hard work of the diabetes community culminate in the unprecedented patient discussion with the FDA on Nov. 3. It would not have been possible without the enormous help of the FDA staff who so generously agreed to partner with us, and […]
So many people tuned in for the first-ever virtual town hall discussion between the D-Community and FDA, that the agency’s ability to livestream the three-hour meeting online slowed and eventually crashed. And it wasn’t only our diabetes dialogue… it seems the FDA’s entire network of webcast meetings shut down for a couple hours at least.
Just before we hit November, the big National Diabetes Awareness Month, it’s worth taking a moment to look back on what this past month has brought us from the Diabetes Online Community Halloween Roundup Icon(DOC). There’s been a whole lot of action in October, and despite today’s Halloween theme, the posts we’ve seen have served […]
The Consensus Conference on Glucose Monitoring took place in Washington D.C. to discuss quality and safety of glucose monitoring. Discussion topics included the need for greater post-market surveillance, the DTS Surveillance Program, the FDA, and two CGM Medicare bills currently in Congress.
Researchers are using electrical stimulation to relieve the pain the condition can cause. If such a treatment method proves successful, it might offer welcome relief and better health outcomes for people with diabetes. One of the first devices to hit the market is Sensus, by NeuroMetrix. Available by prescription, it relies on external electrical stimulation […]
On November 3, the FDA will host an unprecedented discussion between the diabetes community and its senior agency leadership (both drugs and devices). The event will be live webcasted from 1 – 4 pm, and will include a panel of people with type 1 and type 2 diabetes, as well as representatives from ADA, JDRF, […]
Cases of tuberculosis are set accelerate worldwide unless action is taken to curb diabetes, a chronic condition that weakens the immune system and triples the risk a person will develop the lung disease, health experts warned on Wednesday.
Updates on islet encapsulation, the artificial pancreas project, Type I prevention and much more.
If you’re over 6 months old, the CDC says yes, you need to get a flu vaccination at the start of every flu season. Despite the fact that we tend to label any illness that makes us sneeze, shiver, or vomit as “the flu,” true influenza isn’t a trivial illness. It can do far worse […]
After a busy summer in the Diabetes Community, we find ourselves transitioning into Fall with just as much activity online! Indeed, the diabetes blogosphere is bristling full of great posts that are just as diverse and beautiful as the changing colors of Fall foliage. Here’s a look at some of our fave posts from September, […]
Are you trying to be the “perfect” person with diabetes? If so, you could be setting yourself up to feel like a failure. Why? Because there is no such thing as the perfect person with diabetes. Setting a goal to have “perfect” blood glucose control is admirable, but the concept of “perfect” blood glucose control […]
Swedish researchers have found that insulin pump users have better medical outcomes than those who use multiple daily injections. Also in recent news, The Juvenile Diabetes Research Foundation has awarded a $500,000 grant for research on an implantable encapsulation device that releases insulin-producing beta cells in the bloodstream of people with Type 1 diabetes.
The biggest annual diabetes conference in Europe took place last week – the European Association for the Study of Diabetes (EASD) — bringing thousands from the D-field this year to Austria, for what many of us in the States refer to as “Europe’s version of the annual ADA Meeting.”
Updates on the European Approval to Launch the Freestyle Libre System, FDA “Tentative Approval” of BI/Lilly’s insulin glargine Basaglar and NIH $20 Million commitment for Pivotal Artificial Pancreas Studies.
The possibility of trauma inducing diabetes has been a topic of interest since Dr. Joslin was practicing medicine in the 1940s. To quote Dr. Joslin from his paper, “The Relation of Trauma to Diabetes,” published in the Annals of Surgery in 1943, “The thesis that trauma de novo can cause diabetes has steadily lost support.”
When news about a startling new insight into the cause of Alzheimer’s disease first emerged in 2005, it was highly speculative. But now the evidence for it has become very strong: Alzheimer’s is a form of diabetes, and the name being given to it is type 3.